| NCT ID | NCT07083973 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | ARDS (Acute Respiratory Distress Syndrome) |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-10-31 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate global and regional changes in lung ventilation and perfusion induced by prone position in ARDS patients assessed by 3D-EIT. And to investigate the difference between 2D-EIT and 3D-EIT in prone position monitoring.
Eligibility Criteria
Inclusion Criteria: * patients on mechanical ventilation. * Diagnosis of ARDS was based on the Berlin definition * Patients in need of prone position because of clinical condition Exclusion Criteria: * Under 18 years of age. * Pregnant women; * Ribcage malformation * Any contraindication to the use of EIT (e.g. automatic implantable cardioverter defibrillator, and implantable pumps).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07083973 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ARDS (Acute Respiratory Distress Syndrome). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07083973 currently recruiting?
Yes, NCT07083973 is actively recruiting participants. Contact the research team at tjmuhhw@163.com for enrollment information.
Where is the NCT07083973 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07083973 clinical trial?
NCT07083973 is sponsored by Peking Union Medical College Hospital. The trial plans to enroll 30 participants.